To include your compound in the COVID-19 Resource Center, submit it here.

Linifanib: Phase II data

In an open-label Phase II trial in 53 patients who previously failed treatment with Sutent sunitinib, 0.25 mg/kg

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE